Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-9035
Bioorg Med Chem Lett 2001 May 07;119:1205-10. doi: 10.1016/s0960-894x(01)00180-9.
Show Gene links Show Anatomy links

Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

Stutzmann JM , Bohme GA , Boireau A , Damour D , Debono MW , Genevois-Borella A , Jimonet P , Pratt J , Randle JC , Ribeill Y , Vuilhorgne M , Mignani S .


???displayArticle.abstract???
The overstimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been implicated in the physiopathogenesis of epilepsy as well as in acute and chronic neurodegenerative disorders. An original series of readily water soluble 4-oxo-10-substituted-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives was synthesized. The most potent derivative 6a exhibited nanomolar binding affinity (IC50 = 35nM) and antagonist activity (IC50 = 6nM) at ionotropic AMPA receptor. This compound also demonstrated potent anticonvulsant properties in MES in mice and rats with long durations of action with ED50 values in the 1-3 mg/kg dose range following ip and iv administration.

???displayArticle.pubmedLink??? 11354378
???displayArticle.link??? Bioorg Med Chem Lett